“Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified As Having Skin of Color: A Post Hoc Analysis of JADE COMPARE”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s733, https://doi.org/10.25251/8r6ert44.